INMB - INmune Bio - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

INMB is currently covered by 1 analysts with an average price target of $7.9. This is a potential upside of $5.92 (298.99%) from yesterday's end of day stock price of $1.98.

INmune Bio's activity chart (see below) currently has 6 price targets and 6 ratings on display. The stock rating distribution of INMB is 50% BUY and 50% SELL.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 40% with an average time for these price targets to be met of 168.6 days.

Highest price target for INMB is $0.6, Lowest price target is $0.6, average price target is $0.6.

Most recent stock forecast was given by GEORGE FARMER from SCOTIABANK on 29-Jun-2025. First documented stock forecast 17-Dec-2019.

Best performing analysts who are covering INMB - INmune Bio:

Jonathan Aschoff Chad Mabry Mayank Mamtani Thomas Shrader George Farmer

Currently out of the existing stock ratings of INMB, 1 are a BUY (50%), 1 are a SELL (50%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Sell

$0.6

$-1.48 (-71.15%)

$23

3 months 10 days ago
(29-Jun-2025)

0/2 (0%)

$-1.71 (-74.03%)

Hold

$7

$-2.18 (-23.75%)

$20

3 years 4 months 15 days ago
(24-May-2022)

1/2 (50%)

$1.52 (27.74%)

13

Buy

$14

$4.82 (52.51%)

$31

3 years 4 months 15 days ago
(24-May-2022)

1/2 (50%)

$8.52 (155.47%)

631

Buy

$34

$31.92 (1534.62%)

$29

4 years 2 months 26 days ago
(13-Jul-2021)

0/2 (0%)

$11.04 (48.08%)

Buy

$26

$23.92 (1150.00%)

$13

5 years 2 months 26 days ago
(13-Jul-2020)

2/2 (100%)

$10.25 (65.08%)

199

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is INMB (INmune Bio) average time for price targets to be met?

On average it took 168.6 days on average for the stock forecasts to be realized with a an average price target met ratio 40

Which analyst has the current highest performing score on INMB (INmune Bio) with a proven track record?

JONATHAN ASCHOFF

Which analyst has the current lower performing score on INMB (INmune Bio) with a proven track record?

GEORGE FARMER

Which analyst has the most public recommendations on INMB (INmune Bio)?

Jonathan Aschoff has 2 price targets and 3 ratings on INMB

Which analyst is the currently most bullish on INMB (INmune Bio)?

Chad Mabry with highest potential upside - $31.92

Which analyst is the currently most reserved on INMB (INmune Bio)?

Mayank Mamtani with lowest potential downside - -$2.18

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?